Nivestym (filgrastim-aafi) is used to treat
neutropenia. Nivestym is a biosimilar for
neupogen (filgrastim). Biosimilars are biologic drugs that are similar to the original medication with no meaningful differences in effectiveness or safety. Nivestym may be covered by your Medicare or insurance plan. With the Patient Assistance Program from Pfizer, you can receive your medication at no cost.